Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a Locations section listing study sites across US states and Canadian provinces. Removed the HHS Vulnerability Disclosure notice and updated the revision tag to v3.3.3.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe update shows a minor site revision from v3.3.1 to v3.3.2 with no evident changes to the study details or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe Publications section gained a PubMed-listed case report citation and a revision note (v3.3.1), while the previous generic publication description was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding/operating status notice has been removed from the page. Previously, this notice informed users about potential delays in updates due to funding.SummaryDifference0.3%

- Check63 days agoChange DetectedThe study record page shows only minor formatting adjustments. All substantive content such as eligibility criteria, outcomes, and location listings remains unchanged.SummaryDifference0.3%

- Check91 days agoChange DetectedUpdate to operating-status notice, new future dates and a newer revision/version; removal of older dates and older Last Update/Revision markers. Overall, signals a status refresh rather than a substantive content overhaul.SummaryDifference4%

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.